Searchable abstracts of presentations at key conferences in endocrinology

ea0090p500 | Thyroid | ECE2023

The iodine study in pregnancy: no correlation between serum thyroglobulin and urinary iodine concentration

Žabkova Kristyna , Kratky Jan , Jiskra Jan , Krausova Adela

Background: Despite obligatory iodination of salt in the Czech Republic, pregnant women with higher demands on iodine intake may be at risk of iodine deficiency with potentially negative consequences for the course of pregnancy and foetal development. Determination of urinary iodine concentration (UIC) is a conventional but not widely available method used to estimate the iodine status. Based on previous studies, serum thyroglobulin (Tg) could serve as a more convenient marker...

ea0090p121 | Endocrine-related Cancer | ECE2023

Thymic Neuroendocrine Tumor Presenting as Cushing’s Syndrome

Krausova Adela , Limanova Zdenka , Sedlačkova Eva , Schutzner Jan , Michalsky David , Hana Vaclav , Jiskra Jan

Introduction: Cushing’s syndrome (CS) is a rare disease with incidence estimated 2-4 cases per million inhabitants per year. ACTH-dependent forms comprise up to 80% of all cases, of which 80% are central and 20% are ectopic, paraneoplastic forms of ACTH-dependent CS. Thymic neuroendocrine tumors (NET) are accounting for 0,4 - 3% of all NET’s with incidence of 0.02/100 000 inhabitants/year. Up to one third of them are hormonally active (secrete adrenocorticotropic hor...

ea0099p518 | Pituitary and Neuroendocrinology | ECE2024

Long-term pharmacotherapy of giant prolactinomas

Hana Vaclav , Vaněčkova Manuela , Krsek Michal , Kosak Mikulaš , Ježkova Jana , Hana jr. Vaclav , Krausova Adela , Diblik Pavel , Kuthan Pavel , Sklenka Petr , Netuka David , Masopust Vaclav , Majovsky Martin , Liščak Roman

Giant prolactinomas (GPs) are prolactin secreting pituitary adenomas (PitNETs) ≥4 cm, usually with prolactinaemia over 1000 mg/l and without co-secretion of other hormones. Aims: evaluation of long term treatment of GPs, the effect of D2 agonists and of different doses on prolactinaemia, tumour shrinkage and complications.Patients and methods: 33 patients (27 males, 82%) diagnosed with GP in our department between 1997 - 2020...